U.S. market Closed. Opens in 12 hours 2 minutes

RVPH | Reviva Pharmaceuticals Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312020-02-292019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of RevenueN/AN/A724.74KN/AN/A
Gross ProfitN/AN/A-724.74KN/AN/A
Operating Expenses24.31M10.10M2.43M376.86K376.86K
Selling, General & Admin5.36M5.25M2.14M181.12K181.12K
Research & Development18.95M4.85M295.15K195.74K195.74K
Other Operating ExpensesN/AN/AN/AN/AN/A
Operating Income-24.31M-10.10M-2.43M-376.86K-376.86K
Other Expenses / Income-11.91K1.59M-1.35M-469.17K-469.17K
Before Tax Income-24.32M-8.52M-3.78M-846.03K-846.03K
Income Tax Expenses20.78K6.00K800.00800.00800.00
Net Income-24.34M-8.52M-3.78M-846.83K-846.83K
Interest Expenses182.80K2.41K1.45M469.37K469.37K
Basic Shares Outstanding19.52M14.79M3.06M2.77M2.77M
Diluted Shares Outstanding19.52M14.79M3.06M2.77M2.77M
EBITDA-24.11M-10.10M-2.33M-376.01K-376.01K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-24.14M-8.51M-2.33M-376.66K-376.66K
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312020-02-292019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙